Current Evidence, Patient Selection, and Dental Risk Reduction After Head and Neck Radiation
Osteoradionecrosis, commonly abbreviated as ORN, is a serious late complication of radiation therapy involving the jaw. It occurs when irradiated bone becomes devitalized and loses the ability to heal normally. Patients may develop exposed bone, persistent pain, infection, drainage, fistulas, difficulty eating, or pathologic fracture.
Hyperbaric oxygen therapy, or HBOT, has historically been used before and after dental extractions to reduce the risk of ORN. That practice remains familiar within hyperbaric and oral surgery communities, but the evidence has changed. Current multidisciplinary guidance does not recommend routine prophylactic HBOT for every patient who needs dental surgery after head and neck radiation. Instead, prevention begins with dental care before radiation, lifelong oral disease control, review of the radiation dose delivered to the jaw, and careful planning of any invasive procedure. (OMS Group)
What Is Osteoradionecrosis of the Jaw?
ORN is generally characterized by necrotic jawbone within an area previously exposed to therapeutic radiation, without recurrent cancer directly explaining the bone abnormality. It may appear as visibly exposed bone, bone that can be probed through a periodontal pocket or fistula, or a radiographic area of lytic or sclerotic change.
Radiation affects bone, soft tissue, and the small blood vessels that support them. Progressive vascular injury, fibrosis, cellular depletion, and impaired remodeling can leave the jaw less capable of recovering from infection, trauma, or surgery. A dental extraction that would normally heal uneventfully may therefore result in a persistent socket, exposed bone, infection, or progressive necrosis within a heavily irradiated area. (UHMS)
The mandible is affected more often than the maxilla because of differences in anatomy, blood supply, bone density, and the radiation dose received during treatment. The clinical consequences may range from a small area of exposed bone to extensive mandibular destruction requiring segmental resection and microvascular reconstruction.
Which Patients Are at Higher Risk for Osteoradionecrosis?
Risk is not determined by a history of head and neck radiation alone. The location and dose of radiation, the condition of the teeth, the proposed procedure, and the patient’s broader health all matter.
The 2024 ISOO-MASCC-ASCO guideline considers patients whose mandible or maxilla received at least 50 Gy to be at increased risk. The guideline also identifies poor oral hygiene, dentoalveolar surgery, and tobacco use as important modifiable risk factors.
Risk assessment should consider:
- The radiation dose delivered to the proposed surgical site
- The volume of mandible or maxilla included in the radiation field
- Time since radiation therapy
- Existing periodontal or periapical disease
- Previous dental extractions or oral surgery
- Xerostomia and radiation-related caries
- Tobacco and alcohol exposure
- Diabetes, nutritional status, and immune function
- Prior ORN or delayed healing
- The complexity and traumatic potential of the planned procedure
A radiation oncologist’s treatment plan can be more informative than the total prescribed cancer dose. A patient may have received a high overall dose while the proposed extraction site received substantially less. Conversely, a tooth may lie within a region of the mandible that received a dose associated with meaningful lifetime risk. Current guidance recommends reviewing the original radiation plan before finalizing dental treatment after head and neck radiation.
Prevention Begins Before Radiation Therapy
The most reliable opportunity to reduce ORN risk occurs before radiation begins. Patients receiving therapeutic radiation that may involve the jaws should undergo a comprehensive dental, periodontal, and radiographic assessment as early as possible. The dental team should receive information about the planned treatment field, anticipated jaw dose, and expected radiation start date. (OMS Group)
Teeth with active infection or a poor long-term prognosis may be removed before radiation, particularly when they are expected to lie within a high-dose field. When clinically possible, current guidance advises allowing approximately two weeks of healing between extraction and radiation. Cancer treatment should not be dangerously delayed solely to achieve a preferred dental healing interval.
Prevention also includes:
- Daily prescription-strength topical fluoride when indicated
- Management of periodontal disease and caries
- Treatment of ill-fitting dentures and traumatic appliances
- Smoking cessation
- Education about lifelong ORN risk
- Regular dental surveillance after cancer treatment
- Early management of xerostomia and oral infection
Modern radiation planning techniques can also reduce risk by limiting the mean dose to the jaw and the volume of bone receiving more than 50 Gy when tumor coverage permits.
Why Prophylactic HBOT Was Historically Used
The traditional prophylactic approach was developed from the concept that irradiated tissue becomes hypovascular, hypocellular, and hypoxic. By substantially increasing tissue oxygen tension, repeated hyperbaric exposures were intended to stimulate angiogenesis, improve fibroblast function, and strengthen the healing environment before surgery.
A widely recognized historical protocol used 20 HBOT sessions before an extraction or other invasive dental procedure, followed by 10 sessions after surgery. This became known as the 20/10 protocol. (PubMed Central (PMC))
The biologic rationale remains plausible. HBOT increases dissolved plasma oxygen and temporarily elevates oxygen availability in tissue supplied by functioning vessels. Repeated exposures may support vascular and connective-tissue responses within selected delayed radiation injuries. However, a credible mechanism does not establish that every irradiated patient receives a meaningful preventive benefit. (PubMed)
What Current Evidence Says About Routine Prophylactic HBOT
The strongest modern trial evaluating prevention is the HOPON study. It enrolled patients requiring dental extractions or implant placement in mandibular regions that had received more than 50 Gy. Participants received antibiotics and chlorhexidine, while the intervention group also completed 30 HBOT sessions at 2.4 ATA. (PubMed Central (PMC))
A total of 144 patients were randomized, with 100 included in the primary analysis. At six months, ORN occurred in 6.4 percent of patients assigned to HBOT and 5.7 percent of controls. The study did not demonstrate a preventive advantage for routine HBOT, although the overall event rate was lower than historically expected and the hyperbaric group reported fewer acute symptoms. (PubMed)
Based on the available evidence, the 2024 ISOO-MASCC-ASCO guideline states that routine prophylactic HBOT before dental extractions is not recommended. This was a weak recommendation based on low-quality evidence, reflecting both the absence of demonstrated routine benefit and continuing uncertainty in narrowly defined high-risk circumstances. (ASCOPubs)
This is an important distinction. Current evidence does not show that HBOT is ineffective in every patient. It shows that applying a lengthy hyperbaric protocol to all previously irradiated patients undergoing extraction is not supported.
When Prophylactic HBOT May Still Be Considered
Current guidance allows that prophylactic HBOT may be offered selectively when an invasive procedure will involve a site where a substantial volume of the mandible or maxilla received more than 50 Gy. The decision should be individualized rather than based on radiation history alone.
A selective hyperbaric consultation may be reasonable when several high-risk features are present, such as:
- A very high dose to the proposed surgical site
- Previous ORN in the same or adjacent area
- A history of markedly delayed healing
- Extensive surgery rather than a simple extraction
- Poor soft-tissue quality within the radiation field
- Limited reconstructive options if healing fails
- Multiple interacting medical or local risk factors
- A procedure involving a particularly vulnerable mandibular region
The consultation should include the oral or maxillofacial surgeon, radiation oncologist, dental specialist, and hyperbaric physician. The team should define the anticipated benefit, available alternatives, planned surgical technique, and consequences if healing does not occur.
HBOT should not be presented as a guarantee against ORN. Even after prophylactic treatment, patients still require careful surgery, infection control, oral hygiene, and close follow-up.
Planning Dental Extractions After Head and Neck Radiation
Whenever possible, clinicians should consider alternatives to extraction in high-risk regions. Endodontic therapy, restoration, crown modification, or symptom-directed management may preserve a tooth without exposing irradiated bone. Dental implants in high-risk regions also require careful assessment because implant placement creates a surgical injury within the jaw.
When extraction is unavoidable, the procedure should be planned using the least traumatic approach that will accomplish the clinical objective. Excessive periosteal stripping, unnecessary bone removal, and poorly controlled soft-tissue injury may further compromise the healing environment.
Current guidance supports considering perioperative antibiotics for higher-risk patients and antiseptic mouth rinses when socket healing is delayed. It also gives a weak, low-evidence recommendation for pentoxifylline and tocopherol around invasive dental procedures in selected patients exposed to at least 50 Gy at the treatment site, provided there are no contraindications such as increased bleeding risk. These measures require individualized prescribing and should not be started without oversight from the treating team.
Primary soft-tissue closure may be appropriate when it can be achieved without excessive tension or additional tissue disruption. The patient should be monitored until mucosal healing is complete rather than discharged from follow-up after a brief symptom-free period.
What a Prophylactic HBOT Course May Involve
When HBOT is selected, the precise protocol is prescribed by the hyperbaric physician in coordination with the surgical team.
Historical protocols commonly involved treatment before and after the dental procedure. The HOPON trial used 30 daily hyperbaric exposures, delivering 100 percent oxygen at 2.4 ATA for approximately 80 to 90 minutes. (PubMed Central (PMC))
A clinical course may include:
- Hyperbaric medical evaluation and risk screening.
- Review of radiation dosimetry and the planned dental procedure.
- Preoperative HBOT sessions.
- Atraumatic dental surgery with appropriate infection-control measures.
- Postoperative HBOT when included in the selected protocol.
- Continued oral surgery follow-up until the socket or surgical site has healed.
An untreated pneumothorax is generally considered an absolute contraindication to HBOT. Ear or sinus equalization problems, pulmonary disease, unstable heart failure, seizure risk, blood glucose management, medications, and implanted devices require patient-specific assessment.
Risks and Practical Burden of Prophylactic HBOT
HBOT is generally well tolerated in appropriately screened patients, but it is not risk free. Potential adverse effects include middle-ear or sinus barotrauma, temporary myopic vision changes, claustrophobia, pulmonary oxygen effects, blood glucose changes, and rare oxygen-induced seizure.
Prophylaxis also creates a substantial logistical burden. A patient may need to attend treatment five days per week, complete sessions before surgery, coordinate the dental procedure within a specific timeframe, and return for additional postoperative treatments.
Transportation, work, caregiving responsibilities, treatment fatigue, mobility, and insurance coverage can all influence whether the plan is realistic. These burdens matter when the expected absolute reduction in risk is uncertain.
The preventive decision should therefore compare the patient’s individualized ORN risk against the medical, practical, and financial costs of treatment.
Recognizing Early Signs of Osteoradionecrosis
Prevention does not end when the extraction is completed. Patients and clinicians should monitor for:
- A socket that does not progressively close
- Exposed or palpable bone
- Persistent pain or swelling
- Purulent drainage
- Bad taste or odor
- Numbness or altered sensation
- A nonhealing oral or facial fistula
- Increasing difficulty opening the mouth
- Unexplained loosening of adjacent teeth
These findings require evaluation rather than repeated empiric treatment without diagnosis. Assessment may include direct oral examination, periodontal evaluation, panoramic imaging, cone-beam CT, conventional CT, or MRI depending on the presentation. Recurrent malignancy must remain part of the differential diagnosis when findings are atypical or progressive. (OMS Group)
HBOT used to prevent ORN should also be distinguished from HBOT considered after ORN has developed. Established disease may require antimicrobial therapy, local wound care, medical antifibrotic treatment, debridement, resection, or vascularized reconstruction. Current guidance considers HBOT with surgery an option in selected cancer-free patients, but evidence for treating established jaw ORN also remains limited.
A Multidisciplinary Approach to ORN Prevention
The most effective preventive strategy is not a single procedure. It is a coordinated pathway that begins before radiation and continues throughout survivorship.
Radiation oncologists should minimize avoidable jaw exposure without compromising tumor treatment. Dental specialists should eliminate active disease and educate patients before radiation. General dentists should provide lifelong preventive care and recognize that invasive procedures may require specialist review. Oral surgeons should obtain radiation-dose information and plan procedures according to the specific anatomic risk. Hyperbaric physicians should reserve HBOT for cases in which the expected benefit is clinically credible and clearly defined.
Current evidence does not support routine prophylactic HBOT for every dental extraction after head and neck radiation. It supports thoughtful selection. For a patient with limited jaw exposure and a straightforward procedure, careful dental surgery and follow-up may be sufficient. For a patient with heavily irradiated mandibular bone, previous healing failure, and a high-consequence surgical site, multidisciplinary discussion of HBOT may still be appropriate.
The objective is not simply to complete an extraction without an immediate complication. It is to preserve healthy oral tissue, maintain function, and reduce the lifelong risk of a condition that can profoundly affect nutrition, speech, appearance, comfort, and quality of life.
